Exploring Synergistic Mechanism of Vinegar-processed Olibanum in Treatment of Ulcerative Colitis Based on Bile Acid-regulated "Gut-liver" Crosstalk

PENG Shitao; LIU Zhenli; SONG Zhiqian; WANG Chun; NING Zhangchi

doi:10.13422/j.cnki.syfjx.20230562

您当前的位置：

首页 >

文章列表页 >

Exploring Synergistic Mechanism of Vinegar-processed Olibanum in Treatment of Ulcerative Colitis Based on Bile Acid-regulated "Gut-liver" Crosstalk

更新时间：2023-10-13

- Exploring Synergistic Mechanism of Vinegar-processed Olibanum in Treatment of Ulcerative Colitis Based on Bile Acid-regulated "Gut-liver" Crosstalk
  增强出版
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 21, Pages: 59-68(2023)
- 作者机构：
  
  中国中医科学院中医基础理论研究所，北京 100700
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20230562
  CLC： R22;R28;R943.1;R574.62
- Published：05 November 2023，
  
  Published Online：26 December 2022，
  
  Received：05 November 2022，
- 稿件说明：
扫描看全文
彭诗涛,刘振丽,宋志前等.基于胆汁酸调控“肠-肝”对话探讨乳香醋炙对治疗溃疡性结肠炎的增效作用机制[J].中国实验方剂学杂志,2023,29(21):59-68.

PENG Shitao,LIU Zhenli,SONG Zhiqian,et al.Exploring Synergistic Mechanism of Vinegar-processed Olibanum in Treatment of Ulcerative Colitis Based on Bile Acid-regulated "Gut-liver" Crosstalk[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(21):59-68.
彭诗涛,刘振丽,宋志前等.基于胆汁酸调控“肠-肝”对话探讨乳香醋炙对治疗溃疡性结肠炎的增效作用机制[J].中国实验方剂学杂志,2023,29(21):59-68. DOI： 10.13422/j.cnki.syfjx.20230562.

PENG Shitao,LIU Zhenli,SONG Zhiqian,et al.Exploring Synergistic Mechanism of Vinegar-processed Olibanum in Treatment of Ulcerative Colitis Based on Bile Acid-regulated "Gut-liver" Crosstalk[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(21):59-68. DOI： 10.13422/j.cnki.syfjx.20230562.

摘要

目的

通过比较乳香醋炙前后对胆汁酸的干预作用，从胆汁酸调控“肠-肝”对话的角度探讨乳香醋炙对治疗溃疡性结肠炎（UC）的增效作用机制。

方法

随机将24只SD大鼠分为正常组、模型组、乳香组和醋乳香组，采用2，4，6-三硝基苯磺酸（TNBS）结肠内灌注建立UC大鼠模型；利用超高效液相色谱-三重四级杆-串联质谱法（UPLC-QQQ-MS）测定大鼠结肠中30种胆汁酸含量；采用实时荧光定量聚合酶链式反应（Real-time PCR）和蛋白免疫印迹法（Western blot）从mRNA和蛋白水平检测大鼠“肠-肝”对话分子法尼酯衍生物X受体（FXR）、成纤维细胞生长因子（FGF）15和FGF受体4（FGFR4）的表达变化；借助结合型胆汁酸干预的HcoEpiC细胞模型，模拟UC状态，并根据干预方式的不同，分为空白组、结合型胆汁酸组、乳香组、醋乳香组及主要差异成分3-

-乙酰基-9，11-去氢-

-乳香酸（ADHBA）组，基于Real-time PCR探究乳香醋炙前后及ADHBA对FXR和FGF19 mRNA表达的影响。

结果

与正常组比较，模型组大鼠结合型胆汁酸总量显著上升（

0.01），“肠-肝”对话因子FXR、FGF15和FGFR4的mRNA和蛋白表达均明显降低（

0.05，

0.01）；与模型组比较，乳香和醋乳香组大鼠结合型胆汁酸总量显著下降（

0.01），FXR、FGF15和FGFR4的mRNA和蛋白表达均明显升高（

0.05，

0.01），醋乳香调节强度优于乳香。在细胞实验中，与空白组比较，结合型胆汁酸组HcoEpiC细胞FXR和FGF19的mRNA表达显著降低（

0.01）；与结合型胆汁酸组比较，乳香组、醋乳香组及ADHBA组FXR和FGF19的mRNA表达明显升高（

0.05，

0.01），醋乳香效果更优。

结论

乳香醋炙后，可能通过加剧UC大鼠结肠中结合型胆汁酸水平的下降，进一步增强FXR-FGF15/19-FGFR4“肠-肝”对话因子表达量的上调，从而增强对UC的治疗作用，醋炙前后差异成分ADHBA可能是增效的主要物质基础。

Abstract

Objective

To investigate the synergistic mechanism of vinegar-processed Olibanum on ulcerative colitis（UC） via the bile acids regulating "gut-liver" crosstalk.

Method

Rats were randomly divided into normal group， model group，

Olibanum group and vinegar-processed Olibanum group. UC model of rats was induced by intracolonic instillation of 2，4，6-trinitrobenzenesulfonic acid（TNBS）. Ultra high performance liquid chromatography-triple quadrupole-mass spectrometry（UPLC-QQQ-MS） was used to perform the qualitative analysis of 30 bile acids in the colon of rats. Real-time fluorescence quantitative polymerase chain reaction（Real-time PCR） and Western blot were used to detect changes in the expression of farnesoid X receptor（FXR）， fibroblast growth factor 15（FGF15） and FGF receptor 4（FGFR4） in "gut-liver" crosstalk at mRNA and protein levels. And with the help of HcoEpiC cell model intervened by conjugated bile acids， simulating the UC state， and according to the different modes of intervention， they were divided into the blank group， conjugated bile acid group， Olibanum group， vinegar-processed Olibanum group and 3-

-acetyl-9，11-dehydro-

-boswellic acid（ADHBA） group. The effect of Olibanum before and after processing with vinegar and the main differential component ADHBA on the mRNA expression of FXR and FGF19 were explored by Real-time PCR.

Result

Compared with the normal group， the levels of conjugated bile acids in the model group increased significantly（

0.01）， and the mRNA and protein expressions of "gut-liver" crosstalk factors FXR， FGF15 and FGFR4 decreased significantly（

0.05，

0.01）. Compared with the model group， the content of conjugated bile acids in

the Olibanum group and vinegar-processed Olibanum group was significantly decreased（

0.01）， the mRNA and protein expressions of FXR， FGF15 and FGFR4 were significantly elevated（

0.05，

0.01）， and vinegar-processed Olibanum exhibited superior effects than Olibanum. In cellular experiments， a significant decrease in mRNA expression of FXR and FGF19 was observed in the conjugated bile acid group when compared with the blank group（

0.01）. Compared with the conjugated bile acid group， the mRNA expressions of FXR and FGF19 were significantly higher in the Olibanum， vinegar-processed Olibanum and ADHBA groups（

0.05，

0.01）， and the effect of vinegar-processed Olibanum was more favorable.

Conclusion

Vinegar-processed Olibanum may enhance the ameliorating effect on UC by enhancing the down-regulation of conjugated bile acids in the colon and the up-regulation of FXR-FGF15/19-FGFR4 "gut-liver" crosstalk pathway， and ADHBA may be the main material basis for the synergy.

关键词

乳香醋炙差异成分胆汁酸“肠-肝”对话溃疡性结肠炎增效减毒

Keywords

Olibanumvinegar-processeddifferential ingredientsbile acids"gut-liver" crosstalkulcerative colitisefficacy enhancing and toxicity reducing

references

沈洪.溃疡性结肠炎——中西医的过去、现在和未来［M］.南京：东南大学出版社，2012：36-41.

孙雨晴，查安生.查安生教授肠病治肝理论在溃疡性结肠炎中的辨治浅析［J］.陕西中医药大学学报，2019，42（4）：15-17.

国家药典委员会.中华人民共和国药典：一部［M］.北京：中国医药科技出版社，2020：233.

李继成，余振喜，杨丽嘉.齿叶乳香树胶脂对慢性结肠炎的疗效［J］.国外医药：植物药分册，2002（4）：167.

GUPTA I，PARIHAR A，MALHOTRA P，et al.Effects of Boswellia serrata gum resin in patients with ulcerative colitis［J］.Eur J Med Res，1997，2（1）：37-43.

宁张弛.基于乳香酸成分变化探索乳香醋炙抗炎活性增强的机理研究［D］.北京：中国中医科学院，2019.

梁东蕊，宋志前，宁张弛，等.乳香与醋乳香对溃疡性结肠炎大鼠抗炎作用的对比研究［J］.世界科学技术—中医药现代化，2020，22（1）：101-107.

毛靖，陆兔林.论“肝与大肠相通”［J］.陕西中医，2019，40（7）：927-930.

PERINO A，SCHOONJANS K.Metabolic messengers：bile acids［J］.Nat Metab，2022，4（4）：416-423.

XIANG J，ZHANG Z，XIE H，et al.Effect of different Bile acids on the intestine through enterohepatic circulation based on FXR［J］. Gut Microbes，2021，13（1）：1949095.

HUANG F，ZHENG X，MA X，et al.Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism［J］.Nat Commun，2019，10（1）：4971.

LU Q，WU X，HAN W，et al.Effect of Glycyrrhiza uralensis against ulcerative colitis through regulating the signaling pathway of FXR/P-gp［J］.Am J Transl Res，2021，13（8）：9296-9305.

PENG S，SONG Z，WANG C，et al.Frankincense vinegar-processing improves the absorption of boswellic acids by regulating bile acid metabolism［J］.Phytomedicine，2022，98：153931.

KRUGLIAK C N，TORRES J，RUBIN D T.What does disease progression look like in ulcerative colitis，and how might it be prevented？［J］.Gastroenterology，2022，162（5）：1396-1408.

SENGUPTA K，KRISHNARAJU A V，VISHAL A A，et al.Comparative efficacy and tolerability of 5-loxin and aflapin against osteoarthritis of the knee：A double blind，randomized，placebo controlled clinical study［J］.Int J Med Sci，2010，7（6）：366-377.

NING Z，LIU Z，SONG Z，et al.Application of a strategy based on metabolomics guided promoting blood circulation bioactivity compounds screening of vinegar［J］.Chem Cent J，2017，11（38）：1-12.

NING Z，WANG C，LIU Y，et al.Integrating strategies of herbal metabolomics，network pharmacology，and experiment validation to investigate frankincense processing effects［J］.Front Pharmacol，2018，9：1482.

宁张弛，宋志前，刘元艳，等.不同提取方式对醋乳香中主要乳香酸类成分含量及其抗炎活性的影响［J］.中国实验方剂学杂志，2017，23（22）：14-19.

宁张弛，宋志前，王淳，等.炮制温度和时间对醋乳香外观颜色及6种乳香酸含量的影响［J］.世界科学技术—中医药现代化，2017，19（3）：508-515.

LIANG D，NING Z，SONG Z，et al.The effects of vinegar processing on the changes in the physical properties of frankincense related to the absorption of the main boswellic acids［J］.Molecules，2019，24（19）：1-20.

彭诗涛，刘振丽，王淳，等.基于初级胆汁酸合成探讨乳香醋炙对溃疡性结肠炎的增效机制［J］.中草药，2022，53（1）：107-116.

杨振寰.两种中医证型UC患者炎症反应与肠道菌群和胆汁酸代谢的相关性研究［D］.北京：北京中医药大学，2021.

MONTROSE D C，NISHIGUCHI R，BASU S，et al.Dietary fructose alters the composition，localization，and metabolism of gut microbiota in association with worsening colitis［J］.Cell Mol Gastroenterol Hepatol，2021，11（2）：525-550.

常艺，张相安，郭海霞，等.基于胆汁酸-肠道菌群轴探讨溃疡性结肠炎肝郁脾虚病机的生物学内涵［J］.中国实验方剂学杂志，2023，29（8）：229-236.

GIRARDIN M，HADENGUE A，FROSSARD J L.High prevalence of cholestasis，with increased conjugated bile acids in inflammatory bowel diseases patients［J］.World J Clin Cases，2018，6（4）：44-53.

王素英，谢玉春，闵莉.大柴胡汤加减对胆囊胆固醇结石湿热证小鼠FXR/FGF15/FGFR4信号通路的影响［J］.中国实验方剂学杂志，2022，28（3）：15-24.

KULLAK-UBLICK G A，STIEGER B，MEIER P J.Enterohepatic bile salt transporters in normal physiology and liver disease［J］.Gastroenterology，2004，126（1）：322-342.

魏敏，程文芳，平晶，等.胆汁酸受体FXR和TGR5在溃疡性结肠炎中的表达［J］.胃肠病学，2017，22（8）：465-468.

VAVASSORI P，MENCARELLI A，RENGA B，et al.The bile acid receptor FXR is a modulator of intestinal innate immunity［J］.J Immunol，2009，183（10）：6251-6261.

DALDEBERT E，BIYEYEMEBM M，MERGEY M，et al.Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium［J］.Gastroenterology，2009，136（4）：1435-1443.

DAI J，WANG H，SHI Y，et al.Impact of bile acids on the growth of human cholangiocarcinoma via FXR［J］.J Hematol Oncol，2011，4（41）：1-8.

SUN L，XIE C，WANG G，et al.Gut microbiota and intestinal FXR mediate the clinical benefits of metformin［J］.Nat Med，2018，24（12）：1919-1929.

DEGIROLAMO C，RAINALDI S，BOVENGA F，et al.Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the FXR-FGF15 axis in mice［J］.Cell Rep，2014，7（1）：12-18.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Exploring Synergistic Mechanism of Processing with Vinegar on Olibanum in Treatment of Ulcerative Colitis Based on Intestinal Flora

Exploring Mechanism of Different Processed Products of Baiyaojian and Its Formula in Treating Ulcerative Colitis Based on Serum Metabolomics and Flow Cytometry

Clinical Efficacy and Safety of Qingyusan Capsules in Treatment of Ulcerative Colitis with Syndrome of Large Intestine Dampness-heat

Related Author

LU Wenjie

PENG Shitao

SONG Zhiqian

LIU Zhenli

WANG Chun

NING Zhangchi

WANG Ruisheng

HOU Yafang

Related Institution

Institute of Basic Theory for Chinese Medicine，China Academy of Chinese Medical Sciences

Henan Collaborative Innovation Center for Research and Development on the Whole Industry Chain of Yu-yao，Henan Engineering Research Center of Chinese Traditional Medicine Special Processing Technology， Henan Engineering Technology Research Center for Integrated Production of Chinese Medicine， Henan Provincial Key Laboratory of Traditional Chinese Medicine for Decoction Pieces Processing， Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-constructed by Henan Province & Ministry of Education，Henan University of Chinese Medicine

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Henan University of Chinese Medicine

Henan Province Hospital of TCM/The Second Affiliated Hospital of Henan University of Chinese Medicine

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰